FDA Approves Epclusa for Treatment of Chronic Hepatitis C Infection

The U.S. Food and Drug Administration recently announced that Epclusa is now approved to treat adult patients with chronic hepatitis C...

Jul 01, 2016 | Kim Rodgers

  • Eliminating Viral Hepatitis as a Public Health Threat: The Important Role Local...

    My first job in public health was as a health educator and HIV test counselor at a Federally Qualified Health Center (FQHC) in San...

    Jun 30, 2016 | Alyssa Kitlas

  • Learn More about Infectious Disease & Informatics at 2016 NACCHO Annual

    The 2016 NACCHO Annual Conference will feature a variety of sharing sessions highlighting key focus areas of NACCHO’s Infectious...

    Jun 20, 2016 | Kim Rodgers

  • National Men’s Health Week: Raising Awareness and Promoting Prevention

    June 13-19 marks National Men’s Health Week, providing an opportunity to encourage men to prioritize the health of their body and...

    Jun 17, 2016 | Nicholas Parr

  • NVHR Survey: Accessing Hepatitis C Treatment through Medicaid

    The National Viral Hepatitis Roundtable (NVHR) has launched a short survey collecting information from patients, providers, advocates,...

    Jun 16, 2016 | Kim Rodgers

  • NVHR Launches Hepatitis C Treatment Access Resource Page

    The National Viral Hepatitis Roundtable (NVHR) just launched a new Hepatitis C Treatment Access Resource Page. The page is designed to...

    Jun 16, 2016 | Kim Rodgers

  • Webinar Series: Fighting Hepatitis and HIV Co-infection in Minority Communities

    Hepatitis and HIV co-infection is a major concern among many racial and ethnic minority groups in the U.S. Prevention and education...

    Jun 15, 2016 | Kim Rodgers

  • Jack N. Spencer Award: Call for Nominations

    The CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention is now accepting nominations for the Jack N....

    May 26, 2016 | Kim Rodgers

  • CDC’s Division of Viral Hepatitis Releases 5-Year Strategic Plan

    CDC’s Division of Viral Hepatitis (DVH) has released a 5-year strategic plan (“Division of Viral Hepatitis Strategic Plan,...

    May 25, 2016 | Kim Rodgers

  • FDA Approves Epclusa for Treatment of Chronic Hepatitis C Infection

    The U.S. Food and Drug Administration recently announced that Epclusa is now approved to treat adult patients with chronic hepatitis C virus (HCV), both with and without cirrhosis (advanced liver disease). Read the announcement to learn more about how this decision will widen the scope of treatment options for patients with HCV.

    Jul 01, 2016 | Kim Rodgers

    Eliminating Viral Hepatitis as a Public Health Threat: The Important Role Local Health Departments Play

    My first job in public health was as a health educator and HIV test counselor at a Federally Qualified Health Center (FQHC) in San Diego. There, I taught classes on HIV, STI, Viral Hepatitis, and TB prevention to individuals in alcohol and drug treatment programs and offered field-based rapid HIV testing following the class. After […]

    Jun 30, 2016 | Alyssa Kitlas

    Learn More about Infectious Disease & Informatics at 2016 NACCHO Annual

    The 2016 NACCHO Annual Conference will feature a variety of sharing sessions highlighting key focus areas of NACCHO’s Infectious Disease and Informatics (IDI) portfolio, including: HIV, STI & Hepatitis, Immunization, Emerging Infections and Outbreak Response, and Informatics. For those registrants, or potential registrants, with a special interest in these topics, the IDI Team has...

    Jun 20, 2016 | Kim Rodgers

    National Men’s Health Week: Raising Awareness and Promoting Prevention

    June 13-19 marks National Men’s Health Week, providing an opportunity to encourage men to prioritize the health of their body and mind. Celebrated in June every year, this awareness week can serve as a reminder for men to check in with their health by: Getting a regular checkup, especially to screen for high blood pressure […]

    Jun 17, 2016 | Nicholas Parr

    NVHR Survey: Accessing Hepatitis C Treatment through Medicaid

    The National Viral Hepatitis Roundtable (NVHR) has launched a short survey collecting information from patients, providers, advocates, and others about challenges with accessing hepatitis C treatment through state Medicaid programs. This information will be used to inform the Centers for Medicare & Medicaid Services (CMS) about ongoing barriers. Click here to access the survey.

    Jun 16, 2016 | Kim Rodgers

    NVHR Launches Hepatitis C Treatment Access Resource Page

    The National Viral Hepatitis Roundtable (NVHR) just launched a new Hepatitis C Treatment Access Resource Page. The page is designed to help providers, patients, and advocates with information and tools to help them secure treatment for people living with hepatitis C. The goal is for these resources to contribute to collective efforts to overcome discriminatory restrictions and ensure access to...

    Jun 16, 2016 | Kim Rodgers

    Webinar Series: Fighting Hepatitis and HIV Co-infection in Minority Communities

    Hepatitis and HIV co-infection is a major concern among many racial and ethnic minority groups in the U.S. Prevention and education efforts are hindered by many challenges, including stigma, language barriers, cultural competency and knowledge among providers, and access to services in hard-to-reach communities. The Office of Minority Health Resource Center kicks off a new […]

    Jun 15, 2016 | Kim Rodgers

    Jack N. Spencer Award: Call for Nominations

    The CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention is now accepting nominations for the Jack N. Spencer Award. The award is given “to honor individuals for a career of exceptional contributions to excellence in sexually transmitted disease prevention characterized by outstanding commitment to effective science based programs, continuous innovation, and...

    May 26, 2016 | Kim Rodgers

    CDC’s Division of Viral Hepatitis Releases 5-Year Strategic Plan

    CDC’s Division of Viral Hepatitis (DVH) has released a 5-year strategic plan (“Division of Viral Hepatitis Strategic Plan, 2016-2020“) describing their efforts to decrease incidence and prevalence of viral hepatitis, decrease morbidity and mortality from viral hepatitis, and reduce viral hepatitis-related health disparities. To eliminate viral hepatitis in the United States and...

    May 25, 2016 | Kim Rodgers

    Back to Top